Prospective, multicentre, single-arm phase II trial of pembrolizumab combined with carboplatin and pemetrexed in elderly patients with advanced, non-squamous non-small cell lung cancer

INTRODUCTION: Triplet regimen of carboplatin or cisplatin with pemetrexed and pembrolizumab is a standard treatment for patients with advanced, chemo-naïve, non-squamous non-small cell lung cancer. However, subgroup analysis for patients aged ≥75 years indicated that elderly patients who received th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozawa, Yuichi, Sugimoto, Takeya, Azuma, Yuichiro, Harutani, Yuhei, Yoshikawa, Takanori, Yamamoto, Nobuyuki, Kanai, Kuninobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375432/
https://www.ncbi.nlm.nih.gov/pubmed/32699133
http://dx.doi.org/10.1136/bmjopen-2020-037746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375432/
https://www.ncbi.nlm.nih.gov/pubmed/32699133
http://dx.doi.org/10.1136/bmjopen-2020-037746

Ejemplares similares